What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

When is the Mankind Pharma Limited IPO allotment date?

The basis of allotment for Mankind Pharma Limited IPO is scheduled to be finalized on 4 May 2023.

Where can I check Mankind Pharma Limited IPO allotment status?

You can check your allotment status on the official registrar portal (KFin Technologies Limited) or on the BSE India website using your PAN card number or application number.

When will unallotted IPO application funds be unblocked?

Refund initiation and UPI mandate revocation for unallotted applications starts on or around 5 May 2023.

Mankind Pharma Limited

ListedMainboard

Pharmaceuticals & Healthcare · NSE / BSE

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across a wide range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. The company offers over 36 brands such as Manforce, Moxikind-CV, Amlokind-AT, Prega News, and Gudcef, supported by one of the largest distribution networks of medical representatives in India, with over 80% of doctors prescribing its formulations. Ranked 4th in domestic sales in FY2022, Mankind Pharma has received numerous awards, including The Best of Bharat Awards 2022, National Awards for Manufacturing Competitiveness Silver Medal 2021, and recognition for Best Design in Healthcare and performance management excellence.

Price Band

₹1026 – ₹1080

Issue Size

₹4326 Cr

Lot Size

13 shares

GMP

₹180

+16.7%

Est. Listing

₹1260

at current GMP

Subscribed

15.32x

overall

Open

25 Apr 2023

27 Apr 2023

Allotment

4 May 2023

Refund

5 May 2023

Demat Credit

6 May 2023

Listing

9 May 2023

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Official Registrar Verification

Mankind Pharma Limited Allotment Status

Designated Registrar: KFin Technologies Limited

Check Allotment Status Registrar Portal BSE Portal

Allotment Date

4 May 2023

Basis finalization

Refunds Initiate

5 May 2023

Mandate release

Demat Credit

6 May 2023

Shares in demat

Listing Debut

9 May 2023

Trading begins

How to Check Mankind Pharma Limited IPO Allotment Status

Click the Check on Registrar button above to visit KFin Technologies Limited's allotment portal.
Select Mankind Pharma Limited from the dropdown company list.
Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
Enter your details accurately and solve the Captcha code.
Click Submit / Search to view the number of shares applied and allotted to you.

About Mankind Pharma Limited Public Issue & Market Profile

Mankind Pharma Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹4,326.36 Crores. The shares are offered at a price band of ₹1026 to ₹1080 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Public Issue & Allotment Procedure:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 13 shares (approx. ₹14,040 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Official Allotment Timelines & Registrar Guidance:

Allotment reconciliation will be managed by KFin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-05-06, while un-allotted funds or UPI block mandates will be released on 2023-05-05.

Frequently Asked Questions

What if my name is not showing on the registrar portal?

Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.

How will I receive the refund if I don't get allotment?

Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.